Duration of antiretroviral regimens in treatment-experienced patients in clinical practice

被引：0
|
作者：
Vicente Escudero Vilaplana
Sergio Plata Paniagua
Nicolas Trovato Lopez
Isabel Castillo Romera
Arantza Ais Larisgoitia
Jose Maria Bellon Cano
Maria Sanjurjo Saez
机构：
[1] Hospital General Universitario Gregorio Marañon,
来源：
Retrovirology | / 7卷
关键词：
Control Variable; Viral Load; Primary Endpoint; Treatment Failure; Efavirenz;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Drug Resistance-Associated Mutations in Antiretroviral Treatment-Experienced Patients in Kuwait
    Chehadeh, Wassim
    Albaksami, Osama
    John, Sonia Elezebeth
    Al-Nakib, Widad
    MEDICAL PRINCIPLES AND PRACTICE, 2018, 27 (02) : 152 - 157
  • [22] A comparison of DNA and plasma Trofile results in a treatment-experienced study population prior to initiation of new antiretroviral regimens
    Tashima, K. T.
    Coakley, E.
    Toma, J.
    Mollan, K. R.
    Smeaton, L.
    Gandhi, R.
    Fichtenbaum, C. J.
    Eron, J. J.
    Andrade, A.
    Johnson, V. A.
    Klingman, K. L.
    Manzella, A.
    Napolitano, L.
    Haubrich, R. H.
    ANTIVIRAL THERAPY, 2011, 16 : A112 - A112
  • [23] Virological evolution in HIV treatment-experienced patients with raltegravir-based salvage regimens
    Katlama, C.
    Caby, F.
    Andrade, R. M.
    Schneider, L.
    Canestri, A.
    Ktroza, N.
    Tubiana, R.
    Valantin, M. A.
    Wirden, M.
    Mallet, I.
    Calvez, V.
    ANTIVIRAL THERAPY, 2008, 13 (04) : A13 - A13
  • [24] Quality of life in treatment-experienced multiple myeloma patients: A comparative analysis of therapeutic regimens
    Malta, Jessica S.
    Drummond, Paula L. M.
    Silveira, Livia P.
    Costa, Naiane L.
    Machado, Taisa R. L.
    Santos, Roberta M. M.
    Reis, Adriano M. M.
    Padua, Cristiane A. M.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2020, 29 : 191 - 191
  • [25] Tipranavir in highly antiretroviral treatment-experienced patients: Results from a French prospective cohort
    Allavena, Clotilde
    Flandre, Philippe
    Pugliese, Pascal
    Valantin, Marc-Antoine
    Poizot-Martin, Isabelle
    Cabie, Andre
    Melliez, Hugues
    Cuzin, Lise
    Duvivier, Claudine
    Dellamonica, Pierre
    Raffi, Francois
    SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 2012, 44 (01) : 37 - 43
  • [26] Boosted darunavir for treatment-experienced patients
    不详
    CLINICAL INFECTIOUS DISEASES, 2007, 45 (05) : VI - VI
  • [27] Maraviroc in treatment-experienced patients with HIV-1 infection - experience from routine clinical practice
    S Reuter
    P Braken
    B Jensen
    S Sierra-Aragon
    M Oette
    M Balduin
    R Kaiser
    D Häussinger
    European Journal of Medical Research, 15
  • [28] MARAVIROC IN TREATMENT-EXPERIENCED PATIENTS WITH HIV-1 INFECTION - EXPERIENCE FROM ROUTINE CLINICAL PRACTICE
    Reuter, S.
    Braken, P.
    Jensen, B.
    Sierra-Aragon, S.
    Oette, M.
    Balduin, M.
    Kaiser, R.
    Haeussinger, D.
    EUROPEAN JOURNAL OF MEDICAL RESEARCH, 2010, 15 (06) : 231 - 237
  • [29] Health care resource utilization and costs for treatment-experienced people with HIV switching or restarting antiretroviral regimens since 2018
    Colson, Amy
    Chastek, Ben
    Gruber, Joshua
    Majethia, Sunil
    Zachry, Woodie
    Mezzio, Dylan
    Rock, Marvin
    Anderson, Amy
    Cohen, Joshua P.
    JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2024, 30 (08): : 817 - 824
  • [30] Maraviroc Observational Study: The Impact of Expanded Resistance Testing and Clinical Considerations for Antiretroviral Regimen Selection in Treatment-Experienced Patients
    Willig, James H.
    Wilkins, Sara-Anne
    Tamhane, Ashutosh
    Nevin, Christa R.
    Mugavero, Michael J.
    Raper, James L.
    Napolitano, Laura A.
    Saag, Michael S.
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2013, 29 (01) : 105 - 111
12345